Mixed-type inhibition

Consider the standard Uni Uni mechanism (E + A EX E + P). A noncompetitive inhibitor, I, can bind reversibly to either the free enzyme (E) to form an El complex (having a dissociation constant K s), or to the central complex (EX) to form the EXl ternary complex (having a dissociation constant Xu). Both the slope and vertical intercept of the standard double-reciprocal plot (1/v vx. 1/[A]) are affected by the presence of the inhibitor. If the secondary replots of the slopes and the intercepts (thus, slopes or vertical intercepts vx [I]) are linear (See Nonlinear Inhibition), then the values of those dissociation constants can be obtained from these replots. If Kis = Xu, then a plot of 1/v vx 1/[A] at different constant concentrations of the inhibitor will have a common intersection point on the horizontal axis (if not. See Mixed-Type Inhibition). Note that the above analysis assumes that the inhibitor binds in a rapid equilibrium fashion. If steady-state binding conditions are present, then nonlinearity may occur, depending on the magnitude of the [I] and [A] terms in the rate expression. See also Mixed Type Inhibition... 

CHEMICAL KINETICS MIXED-TYPE INHIBITION MIXED VALENCY MIXING TIME... 

NONCOMPETITIVE INHIBITION MIXED-TYPE INHIBITION Noncompetitive inhibition, limiting case of, MIXED-TYPE INHIBITION NONCOVALENT INTERACTIONS ALLOSTERIC INTERACTION BINDING INTERACTION BINDING ISOTHERM BIOSENSOR... 

Amino-peptidase N (EC 3.4.11.2) Dipeptidyl-peptidase IV ALA- -nitro- anilide 0.25 Mixed-type inhibition Vmax reduced 60% No inhibition... 

Maltase Maltose 2.5-20 Mixed-type inhibition KmaDD = 2Kp, at 10 mg/ml... 

As for deaminase, the kinetic analysis suggests a partial mixed-type inhibition mechanism. Both the Ki value of the inhibitor and the breakdown rate of the enzyme-substrate-inhibitor complex are dependent on the chain length of the PolyP, thus suggesting that the breakdown rate of the enzyme-substrate-inhibitor complex is regulated by the binding of Polyphosphate to a specific inhibitory site (Yoshino and Murakami, 1988). More complicated interactions were observed between PolyP and two oxidases, i.e. spermidine oxidase of soybeen seedling and bovine serum amine oxidase. PolyP competitively inhibits the activities of both enzymes, but may serve as an regulator because the amino oxydases are also active with the polyamine-PolyP complexes (Di Paolo et al., 1995). 

The equilibria shown below represent the simplest scheme for mixed-type inhibition (actually a form of noncompetitive inhibition) ... 

A binds to free E with a dissociation constant Ka (also called Ku, in the Cleland nomenclature). B binds to free E with a dissociation constant -Kb (or Kn). The binding of one substrate may alter the affinity of the enzyme for the other. Thus, A binds to EB with a dissociation constant ctKa. Since the overall equilibrium constant between A and E must be the same regardless of the path taken, B binds to EA with a dissociation constant aKs. o Ka is the same as Km (the K for A at saturating [B]). ocKb is the same as (the for B at saturating [A]). If the rate-limidng step is the slow conversion of EAB to EPQ, we can derive the velocity equation for the forward reaction in the absence of P and Q in the usual manner. In fact, the only difference between the rapid equilibrium random bireactant system and noncompetitive or linear mixed-type inhibition is that now the ternary complex (EAB) is catalyticaUy active, while ESI was not. 

The dimeric stereoisomer alkaloids michellamines A, B and C (38) were obtained From the liane Ancistrocladus korupensis (Ancistrocladaceae). On the basis of their structural similarity to other PKC inhibitors, they have been studied for this activity. Michellamines inhibited rat brain PKC, with IC50 values in the 15-35 pM range. Michellamine B was a non-competitive PKC inhibitor with respect to ATP, whereas mixed-type inhibition was observed when the peptide concentration varied. The results indicate that the dimeric alkaloids bind to the PKC kinase domain and not to its regulatory domain. All three michellamines blocked both the ATP and the... 

Not all inhibitions fall cleanly into one of these three patterns. Frequently a mixed type inhibition is encountered in which and K]vi are affected along with the slopes of the reciprocal plots. There are a variety of mixed type inhibition patterns and these are thoroughly covered elsewhere O so only the simplest of these, that one in which M-I has a lower affinity than M for S and the MSI complex is non-productive, will be discussed here. The equilibria for this type of inhibition are shown in Eqn. 7.38 with a > 1. 

A second derivative of PPMP with a Cig fatty acid rather than the Cio of PDMP showed better activity with an inhibitory constant on the isolated GlcCer synthase of 0.7 [tmol 1 . This inhibition of glucose transfer to Cer showed mixed-type inhibition for Cer, but was noncompetitive for UDP-glucose. Radin suggested the use of PDMP for the treatment of Gaucher s disease. ... 

Several porphyrins bind OPH with nniqne spectrophotometric characteristics resnlting however, in order to form a porphyrin-enzyme complex that is sensitive to the presence of snbstrates of the enzyme, a copper-complexed porphyrin is necessary [30]. Two candidates, a copper-complexed TPPSi and copper-complexed TPPCi (mono(4-carboxy phenyl) porphyrin Rj = CO2A R2 = 803 ) inhibit the activity of OPH in a mixed manner. Mixed inhibition is the inhibition of enzyme activity in a manner such that the maximal enzymatic rate and the concentration needed to achieve half of that rate are both changed. The intersection of the cnrves in the absence and presence of the inhibitor occnrs in the second qnadrant of the Lineweaver-Bnrk plot. Mixed type inhibition involves the interaction of the inhibitor at two or more locations on the enzyme with one of these being the active site. The spectrophotometric characteristics of the porphyrin-enzyme complex are different depending on whether the apo or wild-type enzyme is bonnd by the copper-complexed porphyrins however, the spectrophotometric characteristics are identical for the interaction of TPPSi or TPPCi with either version of the enzyme. Other porphyrins snch as zinc-and iron-complexed TPPSi as well as the metal-free TPPSi and TPPCi do not inhibit the enzymatic activity of OPH. 

When an inhibitor is added to the enzyme reaction, the reaction mixture may comprise more than one enzyme complex, namely ES, El, and/or ESI (Scheme 16.1) (Segel, 1987 Shou et al., 2001). Since the ES concentration ([ES]) decreases with an increase in [I], the rate of product formation (kp[ESJ) can decline (0 general kinetic model used to describe the interaction between substrate (S), inhibitor (I) and enzyme (E). Based on nature of inhibition, inhibition kinetics can be categorized to competitive, noncompetitive, uncompetitive and mixed type inhibitions. 

FIGURE 16.2 Methods to measure values of competitive (a), noncompetitive (b), uncompetitive (c), and mixed type inhibition (d). 

The clinical implications of CYP inhibition by inhibitors are dependent on the in vivo concentration of the inhibitor and the role of that CYP in the metabolism of the coadministered drug (fm) (Table 16.6). Clinical relevance of competitive CYP inhibition to human DDI prediction is given in Table 16.7 (Bjornsson et al., 2003a, 2003b). The equations are used to quantitatively predict DDI potential in human from in vitro competitive, noncompetitive and mixed type inhibition. As a conservative approach, the inhibitor [I]max at steady-state and at the highest clinical dose expected should be used in the estimation of AUC change. It was found that a DDI would likely occur if the ratio of inhibitor Plmax/ i were greater than 1 (Table 16.7). DDIs at the ratios between 1 and 0.1 or below 0.1 are possible or remote. 

May be most inhibitors are mixed-type however competitive and non-competitive behaviors are frequently reported when one effect is significantly stronger than the other. Mixed-type inhibition, as non-competitive inhibition, can be partial or total depending on the activity of the tertiary enzyme-substrate-inhibitor complex. A particular case of mixed-type inhibition is uncompetitive inhibition in this case the enzyme has no preformed site for binding the inhibitor, that can only binds to the enzyme after the substrate has bound to it. This situation is not frequent, with the exception of the case when the substrate itself is the inhibitor in fact, uncompetitive inhibition by high substrate concentration is rather common in enzyme catalyzed reactions. 

For competitive inhibition Kap > K and Vap = V For non-competitive inhibition Kap = K and Vap < V For mixed-type inhibition there are three cases ... 

In mixed-type inhibition case i, the net effect will be negative irrespectively of the values of Kap and Vap. In the other two cases the net effect could be negative (inhibition) or positive (activation) depending on the values of Kap and Vap. If Kap < K and Vap > V the net effect will be positive (activation) irrespectively of the values of Kap and Vap. Activation by products of reaction is not as frequent as inhibition, but cases have been reported where product activation is significant (Wieloch et al. 1982 Illanes et al. 1990). 

Fig. 3.5 Graphical representation of inhibition mechanisms in Lineweaver-Burke double reciprocal plots. Cl competitive inhibition NCI non-competitive inhibition UCI uncompetitive inhibition MTI mixed-type inhibition...

Total non-competitive inhibition Partial non-competitive inhibition Total mixed-type inhibition... 

---